In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 4721-98-6, name is 6,7-Dimethoxy-1-methyl-3,4-dihydroisoquinoline, introducing its new discovery. Recommanded Product: 6,7-Dimethoxy-1-methyl-3,4-dihydroisoquinoline
beta-1-(succinimidoethyl)-6,7-dimethoxydihydroisoquinoline having exihibited a stronger analgesic activity than the methylester of 2-methoxy-8,13-diazaestrone, its structure has been systematically modified in view of establishing a relation between structure and activity. From the results of the test it occurs that several compounds possess a peripheral analgesic activity equal or superior to that of glaphenine and that 1-aminoethyl-6,7-dimethoxydihydroisoquinoline shows a clear however weak central analgesic activity. For all these derivatives it seems that the isoquinoline nucleus is the base of the activity.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 4721-98-6, and how the biochemistry of the body works.Recommanded Product: 6,7-Dimethoxy-1-methyl-3,4-dihydroisoquinoline
Reference：
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem